Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: FYI The is the Q earnings are on the 8TH...

"Wave of MMP Portfolio™ Licensees on the Heels of Reexam Success


CUPERTINO, Calif. – October 5, 2009
– Alliacense announced today a wave of new MMP™ Portfolio licensees less than three weeks after the USPTO announced it's decision to affirm the validity of US’336, the most widely recognized patent in the MMP Portfolio. The new licensees include Harman International, TPV Technology, and Textron Inc., and will result in both upfront and future payments, as the increasing rates of the MMP Licensing Program has made onetime, lump-sum licenses too expensive for some companies"

Share
New Message
Please login to post a reply